Bioventus Inc (BVS)
11.51
+0.10
(+0.88%)
USD |
NASDAQ |
Nov 21, 16:00
11.52
+0.01
(+0.09%)
After-Hours: 20:00
Bioventus Gross Profit Margin (Quarterly): 67.32% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 67.32% |
| June 30, 2024 | 68.54% |
| March 31, 2024 | 68.27% |
| December 31, 2023 | 63.73% |
| September 30, 2023 | 65.28% |
| June 30, 2023 | 65.02% |
| March 31, 2023 | 62.09% |
| December 31, 2022 | 58.96% |
| September 30, 2022 | 65.70% |
| June 30, 2022 | 68.88% |
| March 31, 2022 | 64.54% |
| Date | Value |
|---|---|
| December 31, 2021 | 67.30% |
| September 30, 2021 | 72.61% |
| June 30, 2021 | 69.49% |
| March 31, 2021 | 72.83% |
| December 31, 2020 | 74.52% |
| September 30, 2020 | 72.71% |
| June 30, 2020 | 69.55% |
| March 31, 2020 | 72.78% |
| December 31, 2019 | 75.27% |
| March 31, 2016 | 70.59% |
| March 31, 2015 | 68.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
58.96%
Minimum
Dec 2022
75.27%
Maximum
Dec 2019
68.27%
Average
68.40%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 68.83% |
| Insulet Corp | 69.33% |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 58.37% |
| Catheter Precision Inc | 89.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -18.97% |
| Return on Assets | -4.96% |
| Return on Invested Capital | -6.61% |
| Profit Margin (Quarterly) | -3.47% |
| Operating Margin (Quarterly) | 4.74% |
| Return on Net Operating Assets | -5.42% |